AI assistant
BIO-TECHNE Corp — Director's Dealing 2022
Aug 9, 2022
30718_dirs_2022-08-09_b03e6570-4417-4452-ad35-2ca12946ccac.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2022-08-07
Reporting Person: Kelderman Kim (Pres. Diagnostics & Genom)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-07 | Common Stock | M | 2363 | — | Acquired | 4352 | Direct |
| 2022-08-07 | Common Stock | F | 1214 | $382.97 | Disposed | 3138 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-08-07 | Restricted Stock Units | $ | M | 2363 | Disposed | Common Stock (2363) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $150.7800 | 2025-05-01 | Common Stock (7511) | 7511 | Direct |
| Stock Option (Right to Buy) | $177.3200 | 2025-08-08 | Common Stock (12044) | 12044 | Direct |
| Stock Option (Right to Buy) | $177.3200 | 2025-08-08 | Common Stock (9033) | 9033 | Direct |
| Stock Option (Right to Buy) | $190.4100 | 2026-08-07 | Common Stock (11961) | 11961 | Direct |
| Stock Option (Right to Buy) | $190.4100 | 2026-08-07 | Common Stock (15948) | 15948 | Direct |
| Restricted Stock Units | $ | Common Stock (2015) | 2015 | Direct | |
| Stock Option (Right to Buy) | $267.8700 | 2027-08-05 | Common Stock (8991) | 8991 | Direct |
| Stock Option (Right to Buy) | $267.8700 | 2027-08-05 | Common Stock (11988) | 11988 | Direct |
| Stock Option (Right to Buy) | $267.8700 | 2027-08-05 | Common Stock (8325) | 8325 | Direct |
| Stock Option (Right to Buy) | $267.8700 | 2027-08-05 | Common Stock (8325) | 8325 | Direct |
| Restricted Stock Units | $ | Common Stock (1245) | 1245 | Direct | |
| Stock Option (Right to Buy) | $481.8200 | 2028-08-06 | Common stock (6486) | 6486 | Direct |
| Stock Option (Right to Buy) | $481.8200 | 2028-08-06 | Common Stock (4864) | 4864 | Direct |
Footnotes
F1: Fully exercisable.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F3: On 8/7/2022, the Board of Directors certified vesting of 2,363 performance RSUs.
F4: Options to purchase 3,987 shares vest on each of 8/7/2020, 8/7/2021, 8/7/2022 and 8/7/2023.
F5: Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F6: Options to purchase 2,997 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024.
F7: Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
F8: Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
F9: Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F10: Options to purchase 1,621 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 1,622 shares vest on each of 8/6/2024 and 8/6/2025.